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Highlights 
 The drivers behind the increase in computed tomography (CT) are not well 
characterised. 
 As CT is publicly funded through Australia’s universal healthcare system, 
Medicare, an unevaluated increase in use outside of that driven by 
demographic drivers has potential public health (because ionising radiation is 
used) and health economic implications.  
 In Australia, funded CT procedures are often described by the body site of the 
CT, rather than the indication for use, as opposed to more contemporary 
technology like positron emission tomography, where item descriptors are 
often much more specific.  
 We used Australian CT data to explore demographic drivers versus practice 
change. Change in practice, rather than demography, was the main driver of 
CT increase.  
 This finding invites a prospective effort to specifically define descriptors for 
publicly funded services, and a discussion of whether/how often retrospective 




Background: Funded computed tomography (CT) procedure descriptions in Australia 
often specify the body site, rather than indication for use. This study aimed to 
evaluate the relative contribution of demographic versus non-demographic factors in 
driving the increase in CT services in Australia.  
Methods: A decomposition analysis was conducted to assess the proportion of 
additional CT attributable to changing population structure, CT use on a per capita 
basis (CPC, a proxy for change in practice) and/or cost of CT. Aggregated Medicare 
usage and billing data were obtained for selected years between 1993/4 and 2012/3. 
Results: The number of billed CT scans rose from 33 per annum per 1,000 of 
population in 1993/94 (total 572,925) to 112 per 1,000 by 2012/13 (total 2,540,546). 
The respective cost to Medicare rose from $145.7 million to $790.7 million. Change 
in CPC was the most important factor accounting for changes in CT services (88%) 
and cost (65%) over the study period.  
Conclusions: While this study cannot conclude if the increase is appropriate, it does 
represent a shift in how CT is used, relative to when many CT services were listed for 
public funding. This ‘scope shift’ poses questions as to need for and frequency of 
retrospective/ongoing review of publicly funded services, as medical advances and 
other demand- or supply-side factors change the way health services are used.  




Computed tomography (CT) scanning is a commonly used medical imaging technique 
which takes multiple X-ray images, and assembles them to provide a 3-dimensional 
image (1). Since its introduction in the 1970s, CT technology has advanced 
substantially and its added clinical utility has led to increased use in Australia. 
Organisation for Economic Cooperation and Development (OECD)-collated data for 
Australia estimated that CT non-public hospital examinations (approximately 75% of 
the total (2)) increased 32% between 2007 and 2013, from 83.2 to 109.8 CT 
examinations per 1,000 of population (3). If the increase were due to population 
increases or change in distribution (i.e. reflective of an ageing population) then 
increasing counts of CT and associated costs should be proportionate to these 
changes. Indeed, population ageing is often cited as a major driver of increasing 
health resource utilisation and costs (4). Changes outside of that expected due to 
demographic changes would therefore reflect a change in the way that CT is being 
used. Whilst examining these proportionate changes cannot alone aid judgment in 
whether any ‘change in practice’ is appropriate, it would serve to demonstrate 
changes in the way that CT is being used from the original intention when descriptive 
service parameters were developed and evaluated, and decisions to provide public 
funding made. Whilst the potential for ‘scope shift’ is not unique to CT, it is worth 
examining CT in particular as, because of the radiation dose delivered in addition to 
the cost of the procedure, use of CT outside of settings found to be clinical and 
economically effective has the potential to cause harm, in addition to burden on 
publicly funded health systems. The absolute risk associated with CT radiation at a 
population-level is currently not well characterised. Epidemiological studies 
published to date (5-7) likely over-estimate the risk from CT exposure for adults (8). 
However, existing indirect evidence (e.g. (9)) suggests the risk is non-negligible and 
offers support to the presiding ‘as low as reasonably achievable’ (ALARA) principle 
with respect to ionising radiation in medical imaging (10).  
 
Public funding arrangements for CT in Australia 
 
Australia has a fee-for-service model for CT scanning outside of public hospitals, 
where the Federal Government reimburses private radiology providers for individual 
services through Medicare. Medicare also funds general practitioner (GP), pathology, 
other diagnostic, medical specialist and allied health services, with specific item 
descriptors and the service fee described in the Medicare Benefits Schedule (MBS). 
The ‘benefit’ publicly reimbursed to the provider is usually 85% of the listed schedule 
fee, which the provider can either accept as the total payment, or also charge a co-
payment to the patient. CTs are performed at the request of a medical practitioner, 
often a GP in an out of hospital setting. Services through public hospitals are funded 
through a combination of state and national funding and are typically not reported by 
Medicare.  Since 1998, recommendations for item listing are made by the Medicare 
Services Advisory Committee to the Minister for Health, following extensive health 
technology assessment (11). Prior to this period services were funded without 
assessment and the legacy of this is that many services have extremely non-specific 
(if any) descriptors for their intended use. Examples of this include many CT 
examinations in which the item descriptor merely states the area of the body without 
any identification of the clinical setting under which the examination has been listed 
for funding. In contrast descriptors for more recently funded diagnostic technologies, 
such as magnetic resonance imaging and positron emission tomography, tend to be 
very specific about the circumstances of their use under public funding, reflective of 
advances in health technology assessment and concerns about the impact of 
technological advancement on health budgets over time (12). On 22 April 2015, the 
Minister for Health announced the formation of a taskforce to review whether more 
than 5,700 MBS items could be better aligned with contemporary clinical practice and 
evidence (13). Diagnostic imaging is one of the larger areas for review, due to the 
number of items and since many descriptors have not been re-evaluated since they 
were first included on the MBS  
The present study and implications for health policy 
 
Previous descriptive studies have quantified the increase in CT use (14-20), including 
in Australia (21, 22). However, to our knowledge, no study has analysed the 
proportion of change due to demographic versus non-demographic factors, to infer 
then change in use potentially outside of that intended when the decision to publicly 
fund a service was made. Thus in this study, we aimed to find whether the major 
proportion of change in CT scans and associated costs billed to Medicare was due to 
population size and structure changes, or else the complement of this (i.e. that 
explained by ‘change in practice’)?  
 
Through examining this question for CT in Australia, a broader question of whether 
this situation is occurring for other health services is posed, especially in publicly 
funded health systems where descriptors are broad and where indications for use are 
not clearly characterised. This is especially so in cases where clinical progress may 
have driven change. Thus, analysis of the demographic versus non-demographic 
drivers of CT change in Australia is worthy of consideration by policy makers in 
other settings with similar funding and/or service delivery arrangements.  
Methods  
Data sources 
Population data estimates disaggregated by age, sex and state/territory were sourced 
from the Australian Bureau of Statistics (23). The estimated population was as at June 
of the earlier calendar year (e.g. June 2012 for the 2012/13 fiscal year).  
 
CT scan utilisation data were sourced from publicly available Medicare Benefits 
Schedule (MBS) records, extracting ‘Item I2: Computed Tomography’ (24). The 
MBS lists all services eligible for reimbursement through Australia’s Medicare 
programme. Almost all (~99% (2)) of the CT services provided in public hospitals are 
excluded from these data. These records were categorised by sex, age group and 
state/territory of service. The quarter and year recorded for a service reflected the time 
period that the claim was processed by Medicare. Costs are in Australian dollars as at 
the time of processing. 
Decomposition analysis  
We analysed six separate fiscal years (covering the period 1 July to 30 June): 1993/4, 
1996/7, 2000/1, 2004/5, 2008/9, and 2012/13. The population (P); number of CT 
scans (E); and Medicare benefit paid (T) were extracted for each time period, 
excluding two records for which the age group was not known. From the extracted 
data, the mean number of CT scans per capita (CPC) in each each-specific group j 
was calculated as: CPCj = Ej/Pj. Similarly, the mean cost per episode (CPE) was be 
calculated as: CPEj = Tj/Ej, where Tj is the cost of benefit paid for that time period by 
age-specific group, j. The CPC and CPE were also calculated for the study population 
overall (i.e. aggregating over all j groups). Sub-analyses were conducted for each sex 
(comparing each of the years in the original analysis), and for individual 
state/territories, comparing 1993/4 to 2012/13 only.  
 
The decomposition analysis was based on methods used by Ha and colleagues (25) ; 
the methods are briefly summarised below and described in detail in Appendix 1. 
Firstly, we investigated the proportion of the change in the number of CTs that was 
accounted for by: i) change in population size; ii) change in population distribution 
and iii) change in CPC. The change in CPC metric acted as an indirect measure of 
change in practice (i.e. changes in the clinical indications for CT facilitated by 
technological advancement). One time period was compared to the next successive 
time period. In addition, 2012/13 was compared to 1993/4, which compares across the 
entire duration of our data collection. 
 
The proportionate change in CT count was decomposed into three explanations, 
namely: population growth, age distribution and the CPC metric. To estimate the 
proportion of change due to population growth, we assumed that both the population 
age distribution and number of CTs performed per capita for the latter time period did 
not change from the earlier comparator year. The difference between time periods 
predicted by holding these factors constant, as a proportion of the actual change in CT 
count observed, was attributed to population growth. Relaxing the assumption of the 
age distribution remaining identical between time periods allowed the proportion of 
change attributable to shifting population distribution to be calculated next. Finally, 
the proportion attributable to CPC – a proxy for change in practice - was simply the 
remaining CT growth unexplained by population growth or distribution change.  
 
For the second part of the decomposition analysis, we repeated the approach from part 
one, but with five explanations for the change in cost, these being: i) change in 
population size; ii) change in population distribution; iii) change in CPC; iv) change 
in CT distribution by age group and v) change in CPE. As in the count decomposition, 
each factor was isolated in-turn to account for the change between compared time 
periods (see Appendix 1 for further details). The analyses were conducted using 
Microsoft Excel Version 14.5.5 (Redmond, Washington, United States).  
Results  
Table 1 shows population and Medicare-billed CT scan counts and costs over the 
study period. The Australian population increased in size by 29% between 1993 and 
2012, from 17.7 to 22.7 million. The population age-distribution between these time 
periods shifted toward the right; 11.6% of the population were aged ≥ 65 years in 
1993, compared to 14.2% in 2012. Over four times as many CT scans were billed to 
Medicare in 2012/13 than in 1993/4 (2,540, 546 versus 572,925 respectively). This 
yielded a CPC (per 1,000 of population) of 33 in 1993/4, compared to 112 in 2012/13. 
Appendix 2 shows CT count and cost data disaggregated by sex and age group. Both 
the population and CT count in people aged 85 years or above increased markedly 
over the study period (144% and 1,117%, respectively). The dollar value billed to 
Medicare in 1993/4 was $145.7 million (~$243 million equivalent at December 2012 
(26)); this had increased to $790.7 million by 2012/13. The CPE also increased, from 
$253 to $311.  
 
The results of the decomposition analysis for Medicare-billed CT scan count are 
displayed in Figure 1. The majority of the change in CT count was due to change in 
the CPC (88% from 1993/4 to 2012/13), though this became relatively less important 
over the study period. Conversely, population growth explained only 12% of the 
change in number of CT scans performed from 1993/4 to 1996/7, while it explained 
over a fifth (21.5%) of the change in number of CT scans from 2008/9 to 2012/13. 
Change in population age-distribution accounted for only a small proportion of the 
change in CT scan count (3.9% to 8.3%).  
 
The analysis of change in Medicare-billed cost data showed that change in CPC was 
an important factor explaining the increase in cost over the study period (Figure 2). 
This was especially so when comparing 1996/7 to 2000/1, where the change in CPC 
accounted for 79% of the cost increase. However, for the last two years compared, 
2008/9 versus 2012/13, the change in CPC accounted for only 45% of the cost 
increase. During the study period, change in mean CPE became a more important 
factor in explaining the change in cost, accounting for 37% of the change from 2008/9 
to 2012/13.  
 
Separating data by sex showed the male and female population were evenly 
distributed for the years included in the analysis (proportion female 50.2% to 50.4%), 
though the proportion of scans on females (53.2% to 54.3%) and associated costs 
(52.5% to 53.7%) was just over half. The decomposition analysis with data separated 
for males and females showed similar results to the analysis for both sexes (see Figure 
3 (count) and Appendix 3 (cost)).  
 
The analysis by state/territory, provided in Appendix 4, did show variable CT count 
increases. The lowest proportionate increase in CT was seen in the Australian Capital 
Territory at 240%, while Queensland saw the most increase at 508%. The results of 




Medicare-billed CT scans and associated costs increased markedly over the period 
1993 to 2013. To provide international context within OECD countries, Australia’s 
CT use in 2013 was markedly higher than Finland at 32 per 1,000 population (the 
lowest), but lower than the highest user per capita, Estonia at 495 per 1,000 (3). Our 
analysis shows the main factor associated with CT increase in Australia is an increase 
in CPC, indicative of a change in practice beyond that driven by changes in 
demography and potentially beyond that for which the initial decision for provide 
public funding was based upon. However, the importance of population growth as a 
factor in increasing CT increased over the study period. Likewise, the relative 
importance of CT cost has increased as a factor in explaining the change in total 
expenditure over the study period.  
 
CT scan use increased rapidly as technology developed over the study period, as 
demonstrated by the importance of change in CPC over time. In 1996/7, new MBS 
item descriptors were added for CT imaging (i.e. new publicly funded CT services) 
(27); consistent with the high proportion of change from 1996/7 to 2000/1 explained 
by the change in CPC for both count and cost data. A limitation of the CPC is that it 
implies one scan per person, which is not necessarily the case. Because the aggregate-
level data for MBS-billed CT scans does not identify individual patients, we could not 
disentangle the impact of multiple scans. Sodickson and colleagues (28) found in a 
U.S. setting that multiple CT scanning was very common, with a median of 3 
scans/person amongst a mixed inpatient/outpatient cohort. The impact of multiple 
scanning is likely to mean the proportion driven by change in practice is higher than 
in our estimates, and thus our conclusions are unaltered.  
 
CPE increased in importance as an explanatory factor in the increase in CT cost over 
the study period. Unlike other MBS services, which are indexed against the wage and 
consumer price indices each year, medical diagnostic fees have not been routinely 
indexed since 1998 (27). Changes in schedule fees would thus be expected to account 
for a portion of change in CPE prior to 1998, but are less useful in explaining change 
between 1998 and 2013. The change in CPE is thus more likely to be associated with 
increased use of higher-fee MBS items; this is also indicative of a change in the way 
CT is used in practice. A recent audit report found a 20% increase in the average 
benefit paid for diagnostic imaging services between 2005/6 and 2013/14; this is 
consistent with a 15% increase in CPE from 2004/5 and 2012/13 seen in billing data 
used in our study. The audit authors’ attribute the increase to “growth in the use of 
higher-end technologies and/or changes in clinical practice” (29). As our study aimed 
to quantify the proportion of change in CT scans broadly to demographic versus non-
demographic changes, we have not isolated individual MBS items. The utility of 
doing so is slightly reduced by MBS numbers in Australia indicating the site of CT, 
but not the indication (12). It is possible that such isolation of CT by indication would 
be more enlightening using data from another setting, such as the United Kingdom, 
where the reason for GP visits is recorded, which may allow further exploration of CT 
for specific indications (e.g. lower back pain). Previous work in Western Australia 
found the greatest changes per 1,000 population from 2006/7 to 2011/12 were for 
interventional CT (7.3 to 11.4), followed by facial bones (8.3 to 9.7) (2). MBS-billed 
CT of the spine reduced from 20.8 to 18.8 per 1,000 population (2).  
 
While the proportionate contribution of population size increased over the study 
period, the change in population distribution explains less than 10% of the change in 
CT count and cost over all compared time periods included in the analysis, despite a 
shift to the right. However, this is relative to population growth and non-population 
size/distribution factors and it is clear that some changes in CT distribution have 
occurred, including an increase in CT for those aged 85 years or above.  
 
Our study cannot determine if CT increase beyond that driven by increase in 
population size/ageing is appropriate. Previous Australian work has shown between-
provider variation in CT technique and radiation dose, as well as scanning protocols 
leading to higher doses than reported as being standard in international literature (30). 
Simpson and Hartrick (31) have assessed the appropriateness of general practitioner-
requested thoracic CTs – albeit with a small sample size of 50 – and found the 
majority (n = 34) to be inappropriate in their view. A larger Australian study (N= 
3,533) focused on acute lower back pain found that over a quarter of patients seen by 
GPs were referred for imaging (6.2% specifically for CT) (32), after the publication of 
evidence-based guidelines advising against imaging in the absence of specific clinical 
‘red flags’ (33). Aids, such as those developed by the National Prescribing Service 
(34, 35) and the Western Australian Department of Health (36), have been designed to 
encourage appropriate use of CT, and a Medicare Taskforce is currently undertaking a 
system-wide review of diagnostic imaging  (37).  
 
A study using similar data in Australia found that the increase in CT was greater than 
the corresponding increase in population size from 1994 through 2009, though the 
relative proportions were not quantified (21).  Our study highlights non-demographic 
factors as the major driver of Medicare-billed CT scan increase over two decades, and 
the use of routinely collected administrative data is likely to accurately capture actual 
CT scanning activity in the private sector. The decomposition method is suitable to 
the population-level aggregate data analysed, as opposed to more detailed 
multivariable analysis which could have been applied to individual-level data.   
 
This study has several limitations. Firstly, the costs in this decomposition analysis 
reflect those reimbursed by Medicare and do not include patient co-payments; these 
ranged from 10% of the total fee in 1993 up to 17% by 2004 (24). The Medicare fee is 
an important determinant of the fee structure, making it a reasonable proxy for the 
cost of CT. Secondly, population-level averages may mask variation between 
providers. Thirdly, the before and after study design meant that the individual factors 
contained within the ‘change in practice’ metric are likely to be dynamic over time. 
While factors other than those isolated would ideally be held constant (25), the way 
the decomposition analysis has been used in this study is such that the proportion of 
change accounted for by ‘change in practice’ is simply the complement of that 
explained by changing population size and structure change over time. Whilst we 
have offered several potential non-demographic drivers, the list is not exhaustive. 
Finally, data from public hospitals are omitted from this analysis. An earlier cohort 
study using data from Western Australia found that 74% of CT scans performed from 
2006/7 through 2011/12 were billed to Medicare, rather than delivered in a public 
hospital (2). This analysis found differences between CT in public and private 
settings. For example, head CT was relatively more common in public hospitals (2). 
Brady and colleagues (21) also highlight that this proportion of CT performed in 
public hospitals is higher for children and adolescents, relative to older age groups . 
The results of this decomposition analysis thus cannot necessarily be extrapolated to 
CT in all provider settings in Australia.  
 
Conclusion and implications for policy  
 
Changes in the way CT is utilised, more so than changes in demography, have driven 
an increase in CT services and associated costs billed to Medicare from 1993 through 
2013.  
Because CT item descriptors are typically by body site, rather than more detailed 
descriptors for more recently funded techniques such as magnetic resonance imaging 
and positron emission tomography (12), there is a potential that practice change 
reflects an increase in scope beyond that intended when the decision to publicly fund 
was made. Our analysis therefore invites debate on how often or whether 
retrospective analysis of publicly funded health services is appropriate, and highlights 
the importance of developing specific descriptors in line with the evidence of (cost)-
effectiveness considered via detailed health technology assessment. The method we 
have used can easily highlight areas where ‘scope shift’ may have occurred, which 
may aid to identify areas worthy of more in-depth review. Specific to CT, 
consideration of the demand- and supply side factors involved in the increase is 
warranted (for example, the number of CT scanners per 100,000 population increased 
from an estimated 21 in 1995 to 54 in 2013 (38)), especially given services are 
delivered by private providers. 
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253.1 257.2 258.0 270.1 280.0 311.2 
a. Fiscal year (1 July through 30 June).  
b. The estimated population was as at June of the earlier calendar year (e.g. June 
2012 for the 2012/13 fiscal year). 















Figure 2. Decomposition analysis for Medicare-billed computed tomography scan costs for Australia. 
 
 











Appendix 1. Equations for decomposition analysis 
 
Note that the same process was used for comparing the time period 2009-2013 to 
1993-1997 as that described below for comparing successive time periods. The same 
procedure was also followed when analysing by sex, though including only male or 
only female data, and when analysing data by state/territory.  
 
Decomposition analysis for CT count for period 1993 through 2013 
 
i) To calculate the proportion of change in CT count attributable to 
population growth: 
 
This part of the decomposition analysis holds the population distribution 
and CT per capita constant to assess the proportion of change that can be 
attributed to change in population size between time periods.  
 
(1) Population for each age bracket (Eran+1) = population in age bracket 
(Eran)/Total population (Eran) *Total population (Era n+1) (from raw data) 
 
(2) CT per capita (Era n+1) for each age bracket = CT per capita for age 
bracket (Eran) 
 
(3) Number of CT (Era n+1) for each age bracket = CT per capita (from (2)) 
* Population (from (1))  
 
(4) Total CT count (Era n+1) = ∑ Number of CT (Era n+1) from each age 
bracket.  
 
(5) Proportion change in CT count attributable for population growth from 
Eran to Eran+1 = [Total CT count (Era n+1) (from (4)) – Total CT count 
(Eran) (from raw data)]/[Total CT count (Era n+1) (from raw data) - Total 




ii) To calculate the proportion of change in CT count attributable to change in 
population distribution:  
 
This part of the decomposition analysis holds the CT per capita constant, 
to assess the proportion of change that can be attributed to change in 
population distribution between time periods.  
 
(6) Number of CT (Era n+1) for each age bracket = CT per capita (from (2)) 
* Population (Era n+1 ) (from raw data)  
 
(7) Total CT count (Era n+1) = ∑ Number of CT (Era n+1) from each age 
bracket (from (6)) 
 
(8) Proportion change in CT count attributable to change in population 
distribution = [Total CT count (Era n+1) (from (7)) -– Total CT count (Eran) 
(from (4))]/[Total CT count (Era n+1) (from raw data) - Total CT count 
(Eran) (from raw data)] 
 
iii) To calculate the proportion of change in CT count attributable to change in 
CT per capita:  
 
This part of the decomposition analysis assesses the proportion of change 
in CT count attributable to change in per capita CT, by applying the CT 
distribution by age from the previous time period. The total number of CT 
is the same as in the raw data for the later time period, the equations are 
included regardless for the cost decomposition analysis (see below).  
 
(9) Number of CT (Era n+1) for each age bracket = Number of CT (Eran) 
for age bracket/∑Number of CT (Eran) * ∑Number of CT (Era n+1) (from 
raw data)  
 
(10) Total CT count (Era n+1) = ∑ Number of CT (Era n+1) for each age 
bracket (from (9)) = Total CT count (Era n+1) from raw data.  
 3 
 
(11) Proportion change in CT count attributable to change in CT per capita 
= = [Total CT count (Era n+1) (from (10)) -– Total CT count (Eran) (from 
(7))]/[Total CT count (Era n+1) (from raw data) - Total CT count (Eran) 
(from raw data)] 
 
Decomposition analysis for CT cost for period 1993 through 2013 
 
i) To calculate the proportion of the change in cost attributable to population 
growth: 
 
This part of the decomposition analysis holds the population distribution 
and CT per capita constant to assess the proportion of change that can be 
attributed to change in population size between time periods.  
 
(12) Cost per episode (Era n+1) for each age bracket = Cost per episode for 
age bracket (Era n) (from raw data) 
 
(13) Total benefit paid (Era n+1) for each age bracket = Population (Era n+1) 
for age bracket (from (1)) * CT per capita (Era n+1) for age bracket (from 
(2)) * cost per episode (Era n+1) for age bracket (from (12)) 
 
(14) Total benefit paid (Era n+1) = ∑ Total benefit paid (Era n+1) for each 
age bracket (from (13)) 
 
(15) Proportion of change in CT benefits paid attributable to population 
growth from Eran  to Era n+1  = [Total benefits paid (Era n+1) (from (14)) - 
Total benefits paid (Eran) (from raw data)]/ [Total benefits paid (Era n+1) 





ii) To calculate the proportion of change in cost attributable to change in 
population distribution:  
 
This part of the decomposition analysis holds the CT per capita constant, 
to assess the proportion of change that can be attributed to change in 
population distribution between time periods.  
 
(16) Total benefit paid (Era n+1) for each age bracket = Population (Era n+1) 
for age bracket (from (6)) * CT per capita (Era n+1) for age bracket (from 
(2)) * cost per episode (Era n+1) for age bracket (from (12)) 
 
(17) Total benefit paid (Era n+1) = ∑ Total benefit paid (Era n+1) for each 
age bracket (from (16)) 
 
(18) Proportion of change in CT benefits paid attributable to change in 
population distribution from Eran  to Era n+1  = [Total benefits paid (Era 
n+1) (from (17)) - Total benefits paid (Eran) (from raw data)]/ [Total 




iii) To calculate the proportion of change in cost attributable to change in 
mean per capita CT: 
 
This part of the decomposition analysis assesses the proportion of change 
in CT count attributable to change in per capita CT.  
 
(19) CT per capita (Era n+1) for each age bracket = Number of CT for age 
bracket (Era n+1) for age bracket (from (9))/Population for age bracket (Era 
n+1) (from raw data) 
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(20) Total benefits paid (Era n+1) for each age bracket = Population (Era 
n+1) for age bracket (from raw data) * CT per capita (Era n+1) for age 
bracket (from (19)) * cost per episode (Era n+1) for age bracket (from (12)) 
 
(21) Total benefits paid (Era n+1) = ∑ Total benefit paid (Era n+1) for each 
age bracket (from (20)) 
 
(22) Proportion of change in CT benefits paid attributable to change in per 
capita CT from Eran  to Era n+1  = [Total benefits paid (Era n+1) (from (21)) 
- Total benefits paid (Eran) (17)]/ [Total benefits paid (Era n+1) (from raw 
data) - Total benefits paid (Eran) (from raw data)] 
 
 
iv) To calculate the proportion of change in cost attiributable to the change in 
CT distribution by age group:  
 
For this part of the decomposition analysis, the cost per episode is held 
constant compared to the previous time period, with all other data left as 
the raw data for that time period.  
 
(23) Total benefit paid (Era n+1) for each age bracket = Population (Era n+1) 
for age bracket (from raw data) * CT per capita (Era n+1) for age bracket 
(from raw data) * cost per episode (Era n+1) for age bracket (from (12)) 
 
(24) Total benefits paid (Era n+1) = ∑ Total benefit paid (Era n+1) for each 
age bracket (from (23)) 
 
(25 ) ) Proportion of change in CT benefits paid attributable to change in 
cost due to change in per capita CT from Eran  to Era n+1 = [Total benefits 
paid (Era n+1) (from (24)) - Total benefits paid (Eran) (21)]/ [Total benefits 





v) To calculate the proportion of change in cost attributable to change in 
benefit paid per episode:  
 
This part of the decomposition analysis assesses the proportion of change 
in cost attributable to change in the mean cost per episode  
 
(24) Proportion of change in CT benefits paid attributable to change in 
cost per episode from Eran  to Era n+1 = [Total benefits paid (Era n+1) (from 
raw data) - Total benefits paid (Eran) (24)]/ [Total benefits paid (Era n+1) 
(from raw data) - Total benefits paid (Eran) (from raw data)] 
 
Appendix 2. Medicare-billed computed tomography (CT) scan count and cost data for Australia, including a breakdown by sex and age group.  
  1993/4a 1996/7a 2000/1a 2004/5a 2008/9a 2012/13a 
Populationb 17,667,093 18,310,714 19,153,380 20,127,363 21,498,540 22,721,995 
  Male  Female  Male  Female  Male  Female  Male  Female  Male  Female  Male  Female  
0-4 years 662,989 629,533 665,611 631,438 655,870 623,100 654,340 621,369 707,613 670,615 764,413 724,675 
5-14 years 1,305,410 1,239,594 1,339,478 1,274,788 1,377,301 1,309,796 1,402,451 1,329,981 1,411,650 1,340,626 1,442,309 1,368,481 
15-24 years  1,394,315 1,342,131 1,364,251 1,311,734 1,333,011 1,285,283 1,420,120 1,365,323 1,560,974 1,473,105 1,578,337 1,504,818 
25-34 years 1,415,819 1,411,308 1,431,179 1,431,357 1,430,700 1,445,332 1,439,379 1,444,503 1,512,033 1,494,968 1,655,798 1,628,295 
35-44 years 1,338,869 1,335,272 1,402,797 1,408,273 1,468,188 1,485,321 1,493,140 1,514,955 1,548,930 1,571,105 1,585,083 1,605,701 
45-54 years 1,051,640 1,006,927 1,171,754 1,137,116 1,301,564 1,297,262 1,371,334 1,387,393 1,466,831 1,495,504 1,513,673 1,542,535 
55-64 years 741,581 735,347 773,686 764,196 890,998 870,336 1,057,851 1,043,387 1,203,045 1,210,687 1,284,058 1,305,764 
65-74 years  580,440 658,895 613,550 681,757 631,622 678,724 664,799 700,831 732,116 764,065 879,357 899,714 
75-84 years 256,503 388,325 285,448 420,402 338,559 477,744 398,675 528,671 432,953 543,254 459,956 558,720 
85+ years 50,349 121,846 60,301 141,598 77,518 175,151 90,639 198,222 119,978 238,488 146,907 273,401 
Number of 
CT scans 
575,925 748,756 1,083,189 1,459,958 2,008,071 2,540,546 
  Male  Female  Male  Female  Male  Female  Male  Female  Male  Female  Male  Female  
0-4 years 1,614 1,222 1,445 1,085 1,704 1,187 1,300 1,049 1,394 986 1,292 933 
5-14 years 9,693 7,563 10,951 8,381 14,017 10,763 13,248 10,445 14,789 11,936 15,994 14,181 
15-24 years  21,265 22,425 25,796 26,846 32,237 34,264 36,781 38,418 49,437 50,451 58,046 59,332 
25-34 years 30,845 37,311 38,943 45,339 48,846 57,373 55,246 63,558 70,163 80,652 87,565 94,822 
35-44 years 41,229 49,928 51,397 63,184 70,171 85,240 84,948 103,589 108,061 137,199 127,887 154,386 
45-54 years 47,042 55,733 61,179 76,464 87,326 113,069 110,912 145,449 146,753 196,681 179,268 225,969 
55-64 years 49,629 48,871 62,166 65,529 94,082 103,491 140,301 159,079 192,125 226,395 238,239 274,484 
65-74 years  44,182 49,049 62,002 64,993 96,218 95,537 136,367 137,442 189,291 195,736 259,849 272,751 
75-84 years 20,613 29,022 27,212 41,247 40,977 68,505 80,135 101,936 130,257 143,464 179,877 189,953 
85+ years 3,101 5,588 5,130 9,467 9,238 18,944 12,590 27,165 20,120 42,181 41,803 63,915 





145,739,758 192,566,931 279,414,712 394,367,896 562,255,248 790,716,566 
  Male  Female  Male  Female  Male  Female  Male  Female  Male  Female  Male  Female  
0-4 years 302,994 234,697 275,165 214,913 324,806 231,032 263,401 221,659 286,434 209,979 290,552 224,818 
5-14 years 1,993,789 1,597,522 2,258,932 1,752,010 2,801,011 2,170,709 2,672,719 2,142,858 3,025,342 2,496,636 3,208,025 2,699,854 
15-24 years  4,724,915 5,007,669 5,754,552 6,032,028 7,005,653 7,411,411 8,154,489 8,599,824 11,221,766 11,735,301 14,050,894 14,407,301 
25-34 years 7,381,167 8,730,089 9,256,355 10,470,728 11,268,141 13,013,897 13,204,870 15,155,110 17,294,161 19,945,679 23,638,838 25,429,278 
35-44 years 10,250,235 12,545,915 12,720,853 15,664,682 17,069,541 20,753,574 21,633,672 26,480,989 28,272,773 36,181,212 37,449,337 45,023,459 
45-54 years 12,203,154 14,420,181 15,943,662 19,825,045 22,683,272 29,153,626 30,128,965 38,845,259 41,124,635 54,416,299 56,414,878 69,609,148 
55-64 years 13,494,065 13,030,983 17,234,816 17,725,721 26,184,207 27,999,659 40,521,993 44,231,662 57,282,480 65,090,767 78,928,704 88,087,519 
65-74 years  12,101,115 13,065,719 17,690,081 17,791,624 27,861,566 26,344,026 40,901,190 39,024,640 58,394,729 57,607,255 89,179,814 90,180,577 
75-84 years 5,339,212 7,286,820 7,495,531 10,848,677 11,613,861 18,321,064 23,505,893 28,264,870 39,441,968 41,334,461 60,043,923 60,776,917 








253.1 257.2 258.0 270.1 280.0 311.2 
a. Fiscal year (1 July through 30 June).  
b. The estimated population was as at June of the earlier calendar year (e.g. June 2012 for the 2012/13 fiscal year). 
c. Cost data are at time of processing (i.e. not inflated to current value).  
 











Appendix 4.  Decomposition analysis of Medicare-billed computed tomography scan count and cost comparing 1993/4 to 2012/13, by 
state/territory.  
4a. Decomposition of Medicare-billed computed tomography scan count for Australia comparing 1993/4 to 2012/13, also analysed separately by 
state/territory. 
NSW = New South Wales, VIC = Victoria, QLD = Queensland, SA = South Australia, WA = Western Australia, TAS = Tasmania, ACT = 
Australian Capital Territory, NT = Northern Territory, and AUS = Australia.  
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4b. Decomposition of Medicare-billed computed tomography scan costs for Australia comparing 1993/4 to 2012/13, also analysed separately by 
state/territory. 
 
NSW = New South Wales, VIC = Victoria, QLD = Queensland, SA = South Australia, WA = Western Australia, TAS = Tasmania, ACT = 




Medicare-billed computed tomography (CT) scan count and cost data for  each state and territory, comparing 1993/4 to 2012/13.  





Age group (years) Population
b 





























0-4 438,927 1,395 0.003 192.40 268,400 479,945 964 0.002 224.24 216,164 
5-14 849,984 7,375 0.009 212.53 1,567,424 900,928 11,367 0.013 200.85 2,283,084 
15-24 904,108 17,611 0.019 225.85 3,977,470 964,185 42,908 0.045 243.33 10,440,861 
25-34  955,640 27,706 0.029 241.46 6,689,850 1,036,967 66,058 0.064 271.61 17,941,737 
35-44 899,260 37,214 0.041 254.95 9,487,691 1,013,503 101,597 0.100 295.17 29,988,050 
45-54 702,610 42,802 0.061 262.76 11,246,457 981,602 146,147 0.149 315.56 46,118,013 
55-64 520,109 41,181 0.079 274.47 11,302,774 841,110 186,750 0.222 330.13 61,652,032 
65-74 444,129 38,314 0.086 277.16 10,619,015 591,233 196,551 0.332 340.10 66,846,065 
75-84 230,607 20,171 0.087 264.29 5,331,083 349,925 138,149 0.395 328.42 45,370,614 
85+ 59,506 3,206 0.054 245.69 787,673 146,484 39,865 0.272 294.00 11,720,382 
Total or mean 6,004,880 236,975 0.039 258.58 61,277,837 7,305,882 930,356 0.127 314.48 292,577,002 
a. Fiscal year (1 July through 30 June). 
b. The estimated population was as at June of the earlier calendar year (e.g. June 2012 for the 2012/13 fiscal year).  











































0-4 321,620 495 0.002 186.76 92,447 330,091 392 0.001 239.97 94,068 
5-14 623,854 3,372 0.005 209.65 706,951 675,658 7,261 0.011 182.81 1,327,419 
15-24 697,352 10,229 0.015 224.59 2,297,353 748,038 27,701 0.037 237.76 6,586,095 
25-34  724,306 16,222 0.022 236.78 3,841,072 848,524 44,457 0.052 263.41 11,710,288 
35-44 672,281 20,599 0.031 250.88 5,167,897 802,533 68,174 0.085 286.67 19,543,203 
45-54 517,048 22,954 0.044 261.20 5,995,499 756,733 96,095 0.127 304.87 29,296,937 
55-64 381,696 23,455 0.061 270.45 6,343,421 642,958 120,009 0.187 319.65 38,360,676 
65-74 320,048 23,190 0.072 269.45 6,248,563 462,319 125,934 0.272 331.01 41,685,219 
75-84 167,231 12,978 0.078 251.45 3,263,351 275,915 93,757 0.340 319.21 29,928,018 
85+ 46,951 2,589 0.055 230.65 597,142 128,252 28,593 0.223 282.77 8,085,381 
Total or mean 4,472,387 136,083 0.030 253.92 
34,553,69
6 5,671,021 612,373 0.108 304.74 186,617,304 
a. Fiscal year (1 July through 30 June). 
b. The estimated population was as at June of the earlier calendar year (e.g. June 2012 for the 2012/13 fiscal year).  










































0-4 231,105 487 0.002 177.92 86,646 311,408 504 0.002 231.75 116,803 
5-14 465,657 3,110 0.007 206.81 643,186 597,588 5,853 0.010 215.57 1,261,732 
15-24 500,201 6,784 0.014 231.56 1,570,883 633,467 24,272 0.038 253.68 6,157,304 
25-34  489,208 9,948 0.020 245.70 2,444,233 645,111 37,721 0.058 277.15 10,454,443 
35-44 468,127 13,802 0.029 258.33 3,565,441 645,044 59,965 0.093 297.79 17,856,932 
45-54 365,719 15,588 0.043 270.48 4,216,263 612,768 85,567 0.140 315.92 27,032,744 
55-64 248,582 14,077 0.057 284.26 4,001,576 514,787 107,043 0.208 330.44 35,371,046 
65-74 206,161 13,232 0.064 285.86 3,782,547 351,833 109,682 0.312 338.68 37,147,140 
75-84 106,832 7,044 0.066 268.96 1,894,577 183,689 69,465 0.378 328.53 22,821,292 
85+ 28,196 1,245 0.044 248.68 309,604 72,719 18,367 0.253 295.78 5,432,664 
Total or mean 3,109,788 85,317 0.027 263.90 
22,514,95
6 4,568,414 518,439 0.113 315.66 163,652,100 
a. Fiscal year (1 July through 30 June). 
b. The estimated population was as at June of the earlier calendar year (e.g. June 2012 for the 2012/13 fiscal year).  




































0-4 99,368 166 0.002 195.63 32,475 99,112 178 0.002 219.94 39,150 
5-14 201,035 1,169 0.006 191.42 223,774 194,235 2,104 0.011 188.28 396,134 
15-24 216,209 3,307 0.015 201.74 667,162 220,337 8,211 0.037 241.41 1,982,206 
25-34  229,417 5,420 0.024 213.79 1,158,732 218,829 11,963 0.055 270.32 3,233,852 
35-44 220,276 7,029 0.032 231.21 1,625,201 220,756 18,830 0.085 289.80 5,456,960 
45-54 170,057 7,769 0.046 239.04 1,857,079 228,925 28,438 0.124 306.06 8,703,648 
55-64 128,638 8,058 0.063 246.29 1,984,584 202,882 36,739 0.181 320.64 11,780,104 
65-74 117,051 8,098 0.069 240.87 1,950,530 143,973 39,414 0.274 335.23 13,212,814 
75-84 62,078 4,438 0.071 218.10 967,909 87,890 29,087 0.331 328.91 9,567,086 
85+ 16,545 817 0.049 193.71 158,257 39,515 8,893 0.225 300.17 2,669,406 
Total or mean 1,460,674 46,271 0.032 229.64 10,625,703 1,656,454 183,857 0.111 310.25 57,041,360 
a. Fiscal year (1 July through 30 June). 
b. The estimated population was as at June of the earlier calendar year (e.g. June 2012 for the 2012/13 fiscal year).  



































0-4 126,466 168 0.001 200.63 33,705 162,567 119 0.001 241.34 28,719 
5-14 256,449 1,262 0.005 199.85 252,212 305,096 2,067 0.007 189.11 390,884 
15-24 262,491 3,590 0.014 213.46 766,315 338,830 9,169 0.027 235.55 2,159,784 
25-34  271,854 5,522 0.020 223.06 1,231,742 376,556 14,907 0.040 261.01 3,890,851 
35-44 265,770 7,974 0.030 233.94 1,865,416 351,133 23,114 0.066 285.55 6,600,259 
45-54 194,868 8,995 0.046 237.90 2,139,869 330,095 34,022 0.103 301.76 10,266,352 
55-64 131,220 7,765 0.059 241.23 1,873,114 269,765 42,230 0.157 316.82 13,379,241 
65-74 101,047 7,016 0.069 242.72 1,702,946 171,090 41,612 0.243 333.91 13,894,686 
75-84 52,715 3,459 0.066 227.88 788,249 93,251 27,326 0.293 333.15 9,103,785 
85+ 14,789 587 0.040 209.37 122,899 36,355 6,969 0.192 317.65 2,213,680 
Total or mean 1,677,669 46,338 0.028 232.56 10,776,467 2,434,738 201,535 0.083 307.28 61,928,241 
a. Fiscal year (1 July through 30 June). 
b. The estimated population was as at June of the earlier calendar year (e.g. June 2012 for the 2012/13 fiscal year).  


































0-4 35,162 45 0.001 206.16 9,277 31,710 21 0.001 232.14 4,875 
5-14 72,357 436 0.006 218.57 95,298 63,583 411 0.006 187.21 76,942 
15-24 70,262 1,018 0.014 216.69 220,592 65,702 2,336 0.036 227.09 530,484 
25-34  71,422 1,686 0.024 227.85 384,153 59,102 3,166 0.054 258.70 819,060 
35-44 70,444 2,337 0.033 240.62 562,338 65,535 5,205 0.079 287.69 1,497,434 
45-54 54,301 2,346 0.043 253.96 595,800 72,560 7,882 0.109 308.33 2,430,258 
55-64 40,031 2,279 0.057 257.67 587,234 68,319 11,560 0.169 325.29 3,760,329 
65-74 34,385 2,076 0.060 256.27 532,020 48,574 11,950 0.246 336.01 4,015,343 
75-84 18,675 991 0.053 244.70 242,497 26,607 7,651 0.288 330.62 2,529,543 
85+ 4,620 175 0.038 220.10 38,518 10,507 1,843 0.175 305.77 563,537 
Total or mean 471,659 13,389 0.028 244.06 3,267,727 512,199 52,025 0.102 311.92 16,227,805 
a. Fiscal year (1 July through 30 June). 
b. The estimated population was as at June of the earlier calendar year (e.g. June 2012 for the 2012/13 fiscal year).  









































0-4 22,762 55 0.002 174.82 9,615 25,157 35 0.001 342.77 11,997 
5-14 45,583 399 0.009 186.51 74,419 43,596 469 0.011 187.69 88,027 
15-24 55,568 864 0.016 195.08 168,552 57,602 1,632 0.028 243.79 397,859 
25-34  50,712 1,114 0.022 215.64 240,221 64,038 2,739 0.043 260.99 714,855 
35-44 49,625 1,504 0.030 230.31 346,389 55,030 3,553 0.065 289.08 1,027,116 
45-54 36,216 1,656 0.046 242.88 402,206 48,964 4,596 0.094 314.28 1,444,418 
55-64 18,886 1,295 0.069 253.18 327,867 39,464 5,691 0.144 326.41 1,857,617 
65-74 13,059 1,106 0.085 252.07 278,789 24,005 5,617 0.234 345.84 1,942,596 
75-84 5,560 507 0.091 249.74 126,619 12,224 3,707 0.303 344.23 1,276,074 
85+ 1,331 63 0.047 220.75 13,907 4,996 1,094 0.219 328.56 359,448 
Total or mean 299,302 8,563 0.029 232.23 1,988,584 375,076 29,133 0.078 313.05 9,120,007 
a. Fiscal year (1 July through 30 June). 
b. The estimated population was as at June of the earlier calendar year (e.g. June 2012 for the 2012/13 fiscal year).  









































0-4 17,112 25 0.001 205.04 5,126 18,775 12 0.001 299.50 3,594 
5-14 30,085 133 0.004 210.88 28,047 34,441 643 0.019 130.10 83,657 
15-24 30,255 287 0.009 223.89 64,257 35,364 1,149 0.032 177.20 203,602 
25-34  34,568 538 0.016 225.38 121,253 42,364 1,376 0.032 220.23 303,030 
35-44 28,358 698 0.025 251.83 175,777 36,200 1,835 0.051 274.03 502,842 
45-54 17,748 665 0.037 255.88 170,162 31,237 2,490 0.080 293.84 731,656 
55-64 7,766 390 0.050 267.89 104,478 22,885 2,701 0.118 316.62 855,178 
65-74 3,455 199 0.058 263.44 52,424 10,134 1,840 0.182 335.07 616,528 
75-84 1,130 47 0.042 249.94 11,747 3,132 688 0.220 326.20 224,428 
85+ 257 7 0.027 216.71 1,517 701 94 0.134 300.34 28,232 
Total or mean 170,734 2,989 0.018 245.83 734,788 235,233 12,828 0.055 276.95 3,552,747 
a. Fiscal year (1 July through 30 June). 
b. The estimated population was as at June of the earlier calendar year (e.g. June 2012 for the 2012/13 fiscal year).  
c. Cost data are at time of processing (i.e. not inflated to current value).  
 
